Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 16, 2023, ContraFect Corporation (the "Company") convened its 2023 Annual Meeting of Stockholders (including any adjournments, continuations or postponements, the "Annual Meeting"). Due to the lack of a quorum, the meeting was adjourned to June 14, 2023.

On June 14, 2023, the Annual Meeting was reconvened. A total of 846,735 shares of common stock were present in person or represented by proxy at the reconvened Annual Meeting, representing approximately 54 percent of the Company's outstanding common stock as of the March 27, 2023 record date. The following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 3, 2023.

Item 1 - Election of eight directors for a term of office expiring on the date of the annual meeting of stockholders in 2024 and until their respective successors have been duly elected and qualified.



                                                  Votes
NOMINEE                              Votes FOR   WITHHELD   Broker Non-Votes
Lishan Aklog, M.D.                    343,909     55,254        447,572
Sol J. Barer, Ph.D.                   364,388     34,775        447,572
Jane F. Barlow                        369,143     30,020        447,572
Steven C. Gilman, Ph.D.               367,665     31,498        447,572
David N. Low, Jr., M.B.A.             367,623     31,540        447,572
Michael J. Otto, Ph.D.                366,978     32,185        447,572

Roger J. Pomerantz, M.D., F.A.C.P. 365,769 33,394 447,572 Cary W. Sucoff, J.D.

                  367,064     32,099        447,572

Item 2 - Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023.



Votes FOR   Votes AGAINST   Votes ABSTAINED   Broker Non-Votes
 812,718       27,698            6,319               0

Item 3 - Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.

Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes


 339,342       54,769            5,052            447,572

Based on the foregoing votes, the eight director nominees were elected and Items 2 and 3 were approved.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses